Drugs / CALCITRIOL

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00804050 Mar 2007 → Mar 2009 myelodysplastic syndrome Fondazione Italiana Sindromi Mielodisplastiche-ETS Terminated No outcome recorded

Evidence & citations 15 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as CALCITRIOL ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as 1,25-dihydroxy vitamin d3 ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as 1,25-hydroxylated vitamin d ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as 1alpha,25-dihydroxycholecalciferol ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as 1alpha,25-dihydroxyvitamin d3 ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as Calcijex ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as Dihydroxyvitamin D3 “This is a prospective, randomized multicenter phase III clinical trial designed to evaluate the safety and activity of comparison between Erythropoietin and Erythropoietin...” NCT00804050
Known as RO 21-5535 ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as Rocaltrol ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as Silkis ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Known as Vectical ChEMBL registry synonym — accepted as the source's own label CHEMBL846
Action Activate “Vitamin D receptor agonist” CHEMBL846
Modality Small molecule CHEMBL846
Route Oral “Dihydroxyvitamin D3 (1 μg os/die)” NCT00804050
Target VDR “Vitamin D receptor agonist” CHEMBL846